Sekisui Medical operates a drug discovery support business, SEKISUI XENOTECH, LLC, which is mainly based in Europe and the United States. In Japan, Sekisui Medical has collaborated with Cyfuse on R&D of 3D liver structures to be used for drug discovery research. safety testing and toxicity evaluation. As Cyfuse has come closer to commercialization of liver structures prepared in their Regenova 3D printer, Sekisui Medical has now raised priority of collaboration with Cyfuse.
Sekisui Chemical news release, September 13, 2018